Alseres Pharmaceuticals Balance Sheet
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Assets | Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash | 4.9 | 4.2 | 8.2 | 2.4 | 1.5 |
| Net Receivables | -- | -- | -- | -- | -- |
| Inventories | -- | -- | -- | -- | -- |
| Other Current Assets | 1.7 | 1.0 | 1.1 | 0.9 | 0.4 |
| Total Current Assets | 6.6 | 5.2 | 9.3 | 3.2 | 2.0 |
| Net Fixed Assets | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Other Noncurrent Assets | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 |
| Total Assets | 7.0 | 5.6 | 9.8 | 3.7 | 2.5 |
| Liabilities and Shareholder's Equity | Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
| Current Liabilities | |||||
| Accounts Payable | 4.6 | 2.0 | 3.9 | 3.6 | 3.5 |
| Short-Term Debt | -- | -- | -- | -- | 10.0 |
| Other Current Liabilities | -- | 1.8 | -- | -- | -- |
| Total Current Liabilities | 4.6 | 3.8 | 3.9 | 3.6 | 13.6 |
| Long-Term Debt | 29.1 | 24.1 | 23.2 | 14.5 | 9.0 |
| Other Noncurrent Liabilities | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Total Liabilities | 33.9 | 28.0 | 27.3 | 18.3 | 22.8 |
|
Shareholder's Equity | |||||
| Preferred Stock Equity | -- | -- | -- | -- | -- |
| Common Stock Equity | (26.9) | (22.4) | (17.5) | (14.6) | (20.3) |
| Total Equity | (26.9) | (22.4) | (17.5) | (14.6) | (20.3) |
| Shares Outstanding (mil.) | 20.8 | 20.8 | 20.7 | 20.7 | 0.0 |
This data is provided as per license from EDGAR Online
